Details for Patent: 10,765,750
✉ Email this page to a colleague
Which drugs does patent 10,765,750 protect, and when does it expire?
Patent 10,765,750 protects OMLONTI and is included in one NDA.
This patent has twenty-four patent family members in nineteen countries.
Drugs Protected by US Patent 10,765,750
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Visiox Pharma | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,765,750
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015205179 | ⤷ Sign Up | |||
Brazil | 112016015909 | ⤷ Sign Up | |||
Canada | 2935055 | ⤷ Sign Up | |||
China | 105828818 | ⤷ Sign Up | |||
Eurasian Patent Organization | 031813 | ⤷ Sign Up | |||
Eurasian Patent Organization | 201691244 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |